Group
MedTech Long
20 themes113 tickers
10D rank#45of 129 groups
Curious about healthcare's future? MedTech Long dives into medical devices, advanced diagnostics, and cutting-edge therapies. We track innovation, an aging population, and policy shifts driving growth across AI platforms, regenerative medicine, and beyond.
MedTech Long '24: Lab & Life Sciences Tools+8.86%5.0%
MedTech Long '24: Lab Research & Trials+57.61%5.0%
MedTech Long '24: Medical Devices-12.39%5.0%
MedTech Long '24: Regenerative Med+16.02%5.0%
MedTech Long '24: Trump-Favorable Regs-14.22%5.0%
MedTech Long '25 : US Drug Dev Outsourcing+34.99%5.0%
MedTech Long '25: Adv Bio Therapeutics & Regenerative Med+41.99%5.0%
MedTech Long '25: Aging-Driven Procedures & Care+31.06%5.0%
MedTech Long '25: Cancer Diagnostics, Platforms & Care+83.01%5.0%
MedTech Long '25: Centralized Lab Diagnostics+95.64%5.0%
MedTech Long '25: Consumer Platforms-11.74%5.0%
MedTech Long '25: Diagnostic Platforms+27.38%5.0%
MedTech Long '25: Elective Aesthetics+22.34%5.0%
MedTech Long '25: HC Data & Services+54.76%5.0%
MedTech Long '25: Mental Health+111.85%5.0%
MedTech Long '25: Neuromodulation & Neurotechnology Devices+23.40%5.0%
MedTech Long '25: Wearable Health-24.58%5.0%
MedTech Long '26: CROs+55.49%5.0%
MedTech Long '26: Diagnostics & Early Detection+76.68%5.0%
MedTech Long '26: Life Science Tools & Bioprocessing+19.19%5.0%
As of Jul 10, 2026, 7:14 AM ET
Themes in this group
Build 20260710T074722
| MedTech Long '25: Consumer Platforms | 5 | $3.91B | $19.55B | -0.82% | +0.08% | +7.28% | +0.53% | +2.51% | -11.34% | -9.33% | -54.78% | +42.77% | +7.19% | +11.45% | +26.02% |
| MedTech Long '25: HC Data & Services | 6 | $3.53B | $21.18B | +0.28% | +1.20% | +4.83% | +2.55% | +32.17% | +51.94% | +166.12% | +43.85% | +44.59% | +78.25% | +5.22% | +28.79% |
| MedTech Long '24: Lab & Life Sciences Tools | 10 | $44.15B | $441.54B | -0.95% | +4.44% | +4.69% | +1.02% | -2.18% | +7.33% | +0.14% | -10.55% | +10.47% | +8.17% | -2.47% | +9.49% |
| MedTech Long '25: Centralized Lab Diagnostics | 4 | $11.29B | $45.15B | +1.22% | +4.77% | +3.70% | +2.71% | +15.68% | +96.39% | +448.08% | +4.25% | +41.46% | +184.63% | +2.80% | +38.19% |
| MedTech Long '25: Cancer Diagnostics, Platforms & Care | 10 | $5.50B | $54.97B | +0.07% | +3.11% | +3.68% | +1.47% | +33.81% | +79.34% | +327.24% | -36.71% | +33.34% | +157.88% | +3.28% | +36.87% |
| MedTech Long '26: Diagnostics & Early Detection | 15 | $27.95B | $391.26B | +0.15% | +3.34% | +3.44% | +1.49% | +16.76% | +78.18% | +142.28% | +46.17% | +22.22% | +103.20% | -1.13% | +13.38% |
| MedTech Long '25: Mental Health | 7 | $3.34B | $23.36B | +0.18% | +2.35% | +3.01% | +7.62% | +72.10% | +109.12% | +244.52% | -2.82% | +63.80% | +142.33% | +4.06% | +36.41% |
| MedTech Long '26: Life Science Tools & Bioprocessing | 14 | $40.39B | $565.50B | +0.52% | +3.10% | +2.86% | +2.31% | +6.36% | +18.40% | +12.69% | -15.04% | +16.95% | +26.46% | -2.41% | +11.85% |
| MedTech Long '25: Elective Aesthetics | 8 | $825.6M | $6.60B | +0.03% | +0.61% | +2.83% | +4.39% | +25.14% | +24.37% | +43.53% | -52.89% | +38.56% | +61.59% | +2.20% | +14.24% |
| MedTech Long '24: Regenerative Med | 6 | $917.9M | $5.51B | +0.79% | +0.07% | +2.64% | +3.26% | -8.11% | +13.69% | +20.29% | -50.62% | -3.08% | +9.28% | -12.35% | +36.41% |
| MedTech Long '26: CROs | 7 | $41.97B | $293.78B | -1.25% | +2.32% | +2.05% | -1.27% | +1.69% | +51.38% | +3.07% | +19.71% | +27.18% | +45.86% | -5.27% | +13.71% |
| MedTech Long '25: Adv Bio Therapeutics & Regenerative Med | 6 | $3.29B | $19.75B | +2.44% | +1.72% | +1.10% | +5.89% | +2.95% | +41.62% | +55.53% | +10.36% | -4.49% | +38.51% | +2.16% | +20.62% |
| MedTech Long '25 : US Drug Dev Outsourcing | 8 | $2.89B | $23.15B | -0.07% | +3.48% | +1.01% | -0.04% | +14.62% | +35.70% | +46.95% | -62.93% | +37.22% | +38.18% | +1.67% | +27.70% |
| MedTech Long '25: Wearable Health | 5 | $6.50B | $32.50B | +1.57% | -1.79% | +0.82% | +2.67% | -23.76% | -26.28% | -48.29% | -22.53% | -11.76% | -43.14% | +5.19% | +15.12% |
| MedTech Long '24: Medical Devices | 8 | $22.62B | $180.92B | +1.17% | +0.80% | -0.61% | +2.10% | -15.64% | -11.43% | +31.00% | -22.87% | -7.62% | -17.71% | +10.18% | -10.98% |
| MedTech Long '24: Lab Research & Trials | 7 | $8.75B | $61.28B | +0.55% | +1.66% | -0.72% | -0.33% | +21.12% | +56.54% | +25.76% | -12.89% | +22.26% | +63.78% | +2.27% | +11.44% |
| MedTech Long '25: Aging-Driven Procedures & Care | 11 | $16.10B | $177.12B | +0.64% | +1.96% | -0.77% | +0.85% | -2.25% | +30.29% | +60.35% | +18.07% | +8.93% | +26.44% | -5.10% | +9.43% |
| MedTech Long '24: Trump-Favorable Regs | 8 | $7.64B | $61.12B | +0.51% | -0.20% | -0.96% | +0.19% | -4.68% | -13.58% | -23.93% | -16.71% | -0.68% | -4.52% | +3.16% | +9.27% |
| MedTech Long '25: Neuromodulation & Neurotechnology Devices | 9 | $567.9M | $4.54B | +2.87% | +2.12% | -1.10% | +4.62% | +3.18% | +25.70% | +106.12% | -29.15% | +8.73% | +10.19% | +0.32% | +7.05% |
| MedTech Long '25: Diagnostic Platforms | 7 | $4.69B | $32.86B | -0.39% | +3.06% | -2.54% | -2.82% | +13.62% | +26.70% | +82.14% | -66.59% | +8.51% | +63.26% | +10.77% | +48.01% |
Default: 10D ↓ · Click headers to sort · Shift+click secondary